Goal 3: Advance Translational Research

New treatment for HIV and HIV-related lymphoma

Highly active antiretroviral therapy (HAART), while clearly invaluable, does not halt growth or proliferation of HL, in fact, while AIDS-defining malignancies like Kaposi’s sarcoma (KS) and non-Hodgkin’s lymphoma (NHL) have declined thanks to HAART, the incidence of HL in HIV patients has actually increased, from 14 times higher than that of non-HIV patients in the pre-HAART era to 32 times higher in the HAART era. Typical HL therapies – chemotherapy, radiation and monoclonal antibodies – are not applicable as they hasten progression of HIV by exacerbating underlying immunosuppression. This gap in our clinical armamentarium calls for the development of innovative therapies

Tags (Keywords associated with the idea)


-26 net votes
8 up votes
34 down votes
Idea No. 358